MelanoDB: A dataset of clinical and molecular features of patients with advanced melanoma treated with MAPK inhibitors
Abstract MAPK inhibitors (MAPKi) have revolutionized the treatment of patients with advanced melanoma. However, primary and acquired resistance mechanisms limit their efficacy. Predicting MAPKi response from the tumor baseline features remains challenging due to the limited size of patient cohorts....
Saved in:
| Main Authors: | Sarah Dandou, Julie A. Vendrell, Jérôme Solassol, Baptiste Louveau, Céleste Lebbé, Samia Mourah, Florian Rambow, Eric Richard, Stanislas Du Manoir, Alain Mangé, Peter J. Coopman, Ovidiu Radulescu, Romain M. Larive |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Data |
| Online Access: | https://doi.org/10.1038/s41597-025-05291-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors
by: Julie Delyon, et al.
Published: (2024-11-01) -
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
by: Geoffrey Richard, et al.
Published: (2016-09-01) -
Ultrasonographic Characterization of the db/db Mouse: An Animal Model of Metabolic Abnormalities
by: Francesco Faita, et al.
Published: (2018-01-01) -
Comparative Study of Seven New Dressings in Promoting Chronic Wound Healing in db/db Mice
by: Qiuyun FENG, et al.
Published: (2025-05-01) -
WCN25-695 Defective natriuresis contributes to hyperkalemia in db/db mice during potassium supplementation
by: Peng Wu, et al.
Published: (2025-02-01)